X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (537) 537
Publication (48) 48
Book Chapter (10) 10
Book / eBook (5) 5
Book Review (3) 3
Patent (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (243) 243
hematology (161) 161
index medicus (158) 158
male (134) 134
middle aged (128) 128
female (125) 125
adult (109) 109
aged (104) 104
oncology (72) 72
acute myeloid-leukemia (58) 58
myelodysplastic syndromes (56) 56
transplantation (51) 51
leukemia (45) 45
treatment outcome (44) 44
aged, 80 and over (38) 38
myelodysplastic syndromes - genetics (38) 38
prognosis (37) 37
immunology (34) 34
adolescent (33) 33
myelodysplastic syndromes - therapy (33) 33
stem cells (33) 33
myelodysplastic syndromes - pathology (32) 32
bone-marrow-transplantation (31) 31
cancer (31) 31
myelodysplastic syndrome (31) 31
myelodysplastic syndromes - drug therapy (31) 31
young adult (28) 28
mds (26) 26
mutation (26) 26
abridged index medicus (25) 25
chemotherapy (25) 25
survival (25) 25
hematopoietic stem cells (24) 24
retrospective studies (24) 24
survival analysis (24) 24
alemtuzumab (23) 23
bone marrow (23) 23
therapy (23) 23
antineoplastic agents - therapeutic use (22) 22
hematology, oncology and palliative medicine (22) 22
myelodysplastic syndromes - mortality (22) 22
animals (21) 21
risk factors (21) 21
t cells (21) 21
transplantation, homologous (21) 21
transplantation conditioning - methods (20) 20
analysis (19) 19
myelodysplastic syndromes - diagnosis (19) 19
stem-cell transplantation (19) 19
versus-host-disease (19) 19
follow-up studies (18) 18
hematopoietic stem cell transplantation (18) 18
expression (17) 17
hematopoietic stem cell transplantation - methods (17) 17
leukemia, myeloid, acute - genetics (17) 17
leukemia, myeloid, acute - therapy (17) 17
acute myeloid leukemia (16) 16
disease progression (16) 16
hemic and lymphatic diseases (16) 16
mice (16) 16
risk (16) 16
acute myelogenous leukemia (15) 15
immunotherapy (15) 15
apoptosis (14) 14
bone marrow - pathology (14) 14
care and treatment (14) 14
cell biology (14) 14
classification (14) 14
diagnosis (14) 14
mutations (14) 14
peripheral-blood (14) 14
acute disease (13) 13
acute myeloid leukaemia (13) 13
antibodies, monoclonal, humanized (13) 13
article (13) 13
chromosome deletion (13) 13
immunosuppressive agents - therapeutic use (13) 13
leukemia, myeloid, acute - immunology (13) 13
life sciences (13) 13
prognostic scoring system (13) 13
research (13) 13
scoring system (13) 13
stem cell transplantation (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
azacitidine - therapeutic use (12) 12
bone-marrow (12) 12
genetic aspects (12) 12
hematologic malignancies (12) 12
hematopoietic stem cell transplantation - adverse effects (12) 12
in-vivo (12) 12
recurrence (12) 12
antithymocyte globulin (11) 11
chronic myelomonocytic leukemia (11) 11
colony-stimulating factor (11) 11
flow cytometry (11) 11
malignancies (11) 11
unrelated donors (11) 11
aml (10) 10
anemia (10) 10
antimetabolites, antineoplastic - therapeutic use (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5501 - 5501
Abstract Background: T cell mediated immune dysregulation is an important feature of MDS. The expansion of regulatory T cells (Tregs) is one of the important... 
Journal Article
2011, 1. Aufl., ISBN 1405196262, xxi, 416 p., [4] p. of col. plates
This comprehensive book captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes, molecular... 
Leukemia | Lymphomas | Myelodysplastic syndromes
Book
LEUKEMIA, ISSN 0887-6924, 10/2019, Volume 33, Issue 10, pp. 2495 - 2505
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 09/2019, Volume 25, Issue 9, pp. e277 - e284
The improved success of HLA-matched unrelated donor (MUD) hematopoietic stem cell transplantation (HSCT) for severe aplastic anemia (SAA) in recent decades has... 
Severe aplastic anemia | Hematopoietic stem cell transplantation | Alemtuzumab | Usage | Adults | Eltrombopag | Antithymocyte globulin | Aplastic anemia
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 17, pp. 1674 - 1675
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 08/2018, Volume 32, Issue 4, pp. 595 - 607
Aplastic anemia (AA) is an immune-mediated disorder that overlaps closely with clonal disorders, such as myelodysplastic syndrome and paroxysmal nocturnal... 
Treatment | Somatic mutations | Aplastic anemia | Myeloid neoplasms | GENE-MUTATIONS | MYELODYSPLASTIC SYNDROME MDS | ANTITHYMOCYTE GLOBULIN | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | ONCOLOGY | CLONAL HEMATOPOIESIS | REGULATORY T-CELLS | PREDICTS RESPONSE | HEMATOLOGY | BONE-MARROW FAILURE | DRIVER MUTATIONS | TELOMERE LENGTH
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2012, Volume 2012, pp. 49 - 55
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1043 - 1043
Abstract Introduction Heterozygous RTEL1 mutations have recently been described in familial pulmonary fibrosis (PF) but are not known to be associated with... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4296 - 4296
Abstract Background MDS is characterized by ineffective haematopoiesis and a propensity to leukaemia transformation, with increasing evidence linking immune... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 132 - 132
Abstract Introduction MicroRNAs (miRNAs) are short endogenous non-coding RNAs consisting of 18-25 nucleotides in length which influence gene expression and... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1219 - 1219
Abstract Mutations in the FMS-like tyrosine kinase 3 (FLT3) receptor whether it is internal tandem duplication (ITD) of its juxtamembrane domain or point... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 18, pp. 1725 - 1735
Journal Article
BMJ Case Reports, ISSN 1757-790X, 10/2019, Volume 12, Issue 10, p. e232480
Intractable pruritus without visible primary skin lesions and refractory to antihistamines as a primary presentation of chronic myelomonocytic leukaemia (CMML)... 
Multiple sclerosis | Pathogenesis | Leukemia | Neutrophils | Blood tests | Infections | Pruritus | Patients | Dermatitis | Chemotherapy | Granulocytes | Bone marrow | Skin diseases
Journal Article
European Journal of Haematology, ISSN 0902-4441, 10/2018, Volume 101, Issue 4, pp. 466 - 474
Objective Relapse and graft‐vs‐host disease (GVHD) are still the main complications after allogeneic hematopoietic stem cell transplantation, especially in the... 
unrelated transplant | anti‐thymocyte globulin | alemtuzumab | myeloid disorder | graft‐vs‐host disease prophylaxis | graft-vs-host disease prophylaxis | anti-thymocyte globulin | FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | ACUTE MYELOGENOUS LEUKEMIA | ANTITHYMOCYTE GLOBULIN | ACUTE MYELOID-LEUKEMIA | VERSUS-HOST-DISEASE | MYELODYSPLASTIC SYNDROME | MAINTENANCE THERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Prognosis | Myeloproliferative Disorders - therapy | Humans | Middle Aged | Proportional Hazards Models | HLA Antigens - immunology | Male | Treatment Outcome | HLA Antigens - genetics | Lymphocyte Depletion | Myeloproliferative Disorders - genetics | Graft vs Host Disease - mortality | Antilymphocyte Serum - pharmacology | Hematopoietic Stem Cell Transplantation - adverse effects | Antilymphocyte Serum - therapeutic use | Female | Graft vs Host Disease - prevention & control | Transplantation Conditioning - adverse effects | Unrelated Donors | Myeloproliferative Disorders - complications | Alemtuzumab - pharmacology | Graft vs Host Disease - etiology | Alemtuzumab - therapeutic use | Comorbidity | Mortality | Stem cells | Cytogenetics | Transplantation | Health aspects | Hematopoietic stem cells | Graft-versus-host reaction | Myeloid cells | Transplants & implants | Globulins | Prophylaxis | Stem cell transplantation | Monoclonal antibodies | Histocompatibility antigen HLA | Hemopoiesis
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2673 - 2673
Abstract Introduction Severe aplastic anemia (SAA) is an immune mediated bone marrow failure syndrome characterized, among other features, by reduced numbers... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1221 - 1221
Abstract INTRODUCTION The cohesin complex is a multimeric protein complex reported to have putative roles in post-replicative DNA repair, sister chromatids... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.